Clinical Trials Directory

Trials / Unknown

UnknownNCT03093220

Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data Analysis

Molecular Typing of Adult Community-acquired Pneumonia in China

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Peking University People's Hospital · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Accepted

Summary

Community-acquired pneumonia (CAP) is a heterogeneous disease causing great morbidity, mortality and health care burden globally. Typing methods for discriminating different clinical conditions of the same disease are essential to a better management of CAP. Traditional typing systems based separately on clinical manifestations (such as PSI and CURB-65), pathogens(bacterial types, virulence, drug resistance, etc) or host immune state (immunocompetent, immunocompromised or immunodeficiency). Thus, they are barely able to represent the real disease status nor to precisely predict the mortality. As the development of multi-omic technologies, the relatedness of different phenotypes at a molecular level have revolutionized our ability to differentiate among patients. Our study is aimed at establishing a novel molecular typing method of CAP. Multi-omic (including genomics, transcriptomes, and metabolisms) data obtained from enrolled CAP patients and isolated pathogens would be integrated analyzed and interpreted. Tthe investigators believe that an appropriate molecular typing method would lead to revolutionary changes in current arrangements of CAP.

Conditions

Timeline

Start date
2017-03-01
Primary completion
2018-03-31
Completion
2018-12-01
First posted
2017-03-28
Last updated
2017-03-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03093220. Inclusion in this directory is not an endorsement.

Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data Analysis (NCT03093220) · Clinical Trials Directory